(Total Views: 794)
Posted On: 02/12/2022 3:51:21 AM
Post# of 154179
I work in healthcare and have done so for about 30 years. Covid isn’t going anywhere, this disease will be a problem for years to come. There are variants still popping up and if Leronlimab proves to be the best therapeutic, the demand will be there.
I’m confident the trial is progressing in Brazil. The big question is “where are we at with the trial?”.
While no one knows the answer to that question, I’m hopeful the trial may even be filled by now.
With all the bashing from shorts on how it failed the Covid-19 trials, it would send a strong message if the endpoints were hit and was significantly better than the current standard of care.
What I hope is that it could also be approved for mild-moderate. The delivery method for Leronlimab could drastically change the tides for the healthcare system. Current treatment centers have so called “infusion centers” which require sick individuals to congregate and sit for an hour or more to receive an infusion. Just think how a subcutaneous injection could change the landscape for treatment.
I personally think there are good things happening in Brazil but nothing is going to be said until we have results, an EUA or other major announcement.
From what I understand Monday is a deadline for some payments due. It will be interesting to see if there will be any type of updates?
If still silent but the bond is paid. I would highly suspect a partnership or BO.
Hopeful for a Happy Valentine’s Day. It will be the best present my wife could ever want.
I’m confident the trial is progressing in Brazil. The big question is “where are we at with the trial?”.
While no one knows the answer to that question, I’m hopeful the trial may even be filled by now.
With all the bashing from shorts on how it failed the Covid-19 trials, it would send a strong message if the endpoints were hit and was significantly better than the current standard of care.
What I hope is that it could also be approved for mild-moderate. The delivery method for Leronlimab could drastically change the tides for the healthcare system. Current treatment centers have so called “infusion centers” which require sick individuals to congregate and sit for an hour or more to receive an infusion. Just think how a subcutaneous injection could change the landscape for treatment.
I personally think there are good things happening in Brazil but nothing is going to be said until we have results, an EUA or other major announcement.
From what I understand Monday is a deadline for some payments due. It will be interesting to see if there will be any type of updates?
If still silent but the bond is paid. I would highly suspect a partnership or BO.
Hopeful for a Happy Valentine’s Day. It will be the best present my wife could ever want.
(11)
(0)
